The objective of this article is to group together various management strategies and to
highlight the recent treatment modifications that attempt to target the multimodal etiological …

Cancer cachexia is characterized by the loss of lean body mass with or without the loss of fat
and is associated with increased susceptibility to treatment related toxicities, decreased …

Cancer cachexia, or progressive weight loss, often despite adequate nutrition contributes
greatly to cancer morbidity and mortality. Cachexia is metabolically distinct from starvation or …

Weight loss and malnutrition have long been associated with a poor clinical outcome after
surgery (1). Anorexia, muscle wasting and progressive depletion of adipose tissue have …

Background: Cancer cachexia is considered intractable, with few therapeutic options.
Secondary nutrition impact symptoms (S-NIS) such as nausea may further contribute to …

Loss of body weight in cancer patients strongly influences morbidity and mortality. Recent
studies have suggested that both tumor and host factors play a major role in tissue …

Background & aims Weight loss is a cardinal feature of cachexia and is frequently
associated with reduced food intake and anorexia. It is still unclear how much reduced food …

Cachexia is a multifactorial process of skeletal muscle and adipose tissue atrophy resulting
in progressive weight loss. It is associated with poor quality of life, poor physical function …

Purpose: The present study was designed to evaluate whether daily insulin treatment for
weight-losing cancer patients attenuates the progression of cancer cachexia and improves …

Patients manifesting the syndrome of cachexia of malignancy exhibit an abnormal diabetic
glucose tolerance. In our patients this has been correlated with a marked resistance to …